Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis
Stopped The study stopped due to slow enrollment and low participant compliance.
Conditions
- Fatigue in Multiple Sclerosis
Interventions
Sponsor
Novartis Pharmaceuticals